Dennis Sweitzer

999 total citations
13 papers, 833 citations indexed

About

Dennis Sweitzer is a scholar working on Psychiatry and Mental health, Pharmacology and Molecular Biology. According to data from OpenAlex, Dennis Sweitzer has authored 13 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 6 papers in Pharmacology and 2 papers in Molecular Biology. Recurrent topics in Dennis Sweitzer's work include Schizophrenia research and treatment (8 papers), Bipolar Disorder and Treatment (7 papers) and Treatment of Major Depression (6 papers). Dennis Sweitzer is often cited by papers focused on Schizophrenia research and treatment (8 papers), Bipolar Disorder and Treatment (7 papers) and Treatment of Major Depression (6 papers). Dennis Sweitzer collaborates with scholars based in United States, Sweden and Canada. Dennis Sweitzer's co-authors include Robert M. Hamer, Jeffrey A. Lieberman, Michael D. Jibson, Jamie Mullen, Joseph P. McEvoy, Hongbin Gu, Arthur Lazarus, Peter J. Weiden, Diana O. Perkins and Martha Sajatovic and has published in prestigious journals such as American Journal of Psychiatry, Journal of Allergy and Clinical Immunology and Schizophrenia Research.

In The Last Decade

Dennis Sweitzer

12 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dennis Sweitzer United States 11 672 196 142 102 99 13 833
Mihai Gheorghe Romania 4 802 1.2× 129 0.7× 188 1.3× 219 2.1× 83 0.8× 4 910
R. Tamura United States 8 865 1.3× 236 1.2× 173 1.2× 203 2.0× 48 0.5× 30 1.1k
Joseph Stringfellow United States 7 482 0.7× 130 0.7× 90 0.6× 73 0.7× 60 0.6× 19 669
Stuart Kushner United States 14 1.0k 1.5× 119 0.6× 250 1.8× 96 0.9× 54 0.5× 19 1.2k
P.V. Tran United States 7 938 1.4× 258 1.3× 174 1.2× 230 2.3× 75 0.8× 15 1.2k
Eva Kohegyi United States 10 444 0.7× 158 0.8× 161 1.1× 60 0.6× 58 0.6× 14 772
A Breier United States 5 477 0.7× 93 0.5× 104 0.7× 142 1.4× 61 0.6× 8 555
John Cookson United Kingdom 19 772 1.1× 138 0.7× 99 0.7× 34 0.3× 48 0.5× 62 1.1k
Margaretta Nyilas United States 15 1.2k 1.7× 427 2.2× 313 2.2× 94 0.9× 70 0.7× 28 1.4k
David McDonnell United States 19 1.1k 1.7× 374 1.9× 213 1.5× 153 1.5× 85 0.9× 68 1.3k

Countries citing papers authored by Dennis Sweitzer

Since Specialization
Citations

This map shows the geographic impact of Dennis Sweitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Sweitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Sweitzer more than expected).

Fields of papers citing papers by Dennis Sweitzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Sweitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Sweitzer. The network helps show where Dennis Sweitzer may publish in the future.

Co-authorship network of co-authors of Dennis Sweitzer

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Sweitzer. A scholar is included among the top collaborators of Dennis Sweitzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Sweitzer. Dennis Sweitzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Litman, Robert E., et al.. (2014). The Selective Neurokinin 3 Antagonist AZD2624 Does Not Improve Symptoms or Cognition in Schizophrenia. Journal of Clinical Psychopharmacology. 34(2). 199–204. 29 indexed citations
3.
Velligan, Dawn I., Ronald Brenner, David P. Walling, et al.. (2011). Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia. Schizophrenia Research. 134(1). 59–64. 31 indexed citations
4.
Liebowitz, Michael R., Raymond W. Lam, Ulla Lepola, et al.. (2010). Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial. Depression and Anxiety. 27(10). 964–976. 69 indexed citations
5.
McEvoy, Joseph P., Jeffrey A. Lieberman, Diana O. Perkins, et al.. (2007). Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison. American Journal of Psychiatry. 164(7). 1050–1060. 299 indexed citations
6.
Zhong, Kate, Dennis Sweitzer, Robert M. Hamer, & Jeffrey A. Lieberman. (2006). Comparison of Quetiapine and Risperidone in the Treatment of Schizophrenia. The Journal of Clinical Psychiatry. 67(7). 1093–1103. 54 indexed citations
7.
Mintzer, Jacobo, et al.. (2004). A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone. Current Medical Research and Opinion. 20(9). 1483–1491. 17 indexed citations
8.
McConville, Brian J., et al.. (2003). Long-Term Safety, Tolerability, and Clinical Efficacy of Quetiapine in Adolescents: An Open-Label Extension Trial. Journal of Child and Adolescent Psychopharmacology. 13(1). 75–82. 61 indexed citations
9.
Sajatovic, Martha, et al.. (2002). Efficacy of Quetiapine and Risperidone Against Depressive Symptoms in Outpatients With Psychosis. The Journal of Clinical Psychiatry. 63(12). 1156–1163. 66 indexed citations
10.
11.
Phipatanakul, Wanda, et al.. (2000). A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge. Journal of Allergy and Clinical Immunology. 105(4). 704–710. 37 indexed citations
12.
Schneider, Lon S., Lisa A. Arvanitis, Dennis Sweitzer, & Paul Yeung. (1999). QUETIAPINE MAY REDUCE HOSTILITY IN PATIENTS WITH PSYCHOSES RELATED TO ALZHEIMER's DISEASE. American Journal of Geriatric Psychiatry. 7. 58–58. 10 indexed citations
13.
Juncos, Jorge L., et al.. (1999). QUETIAPINE IMPROVES PSYCHOTIC SYMPTOMS ASSOCIATED WITH PARKISON's DISEASE. American Journal of Geriatric Psychiatry. 7. 45–45. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mihai Gheorghe Breakdown of academic impact, for papers by R. Tamura Breakdown of academic impact, for papers by Joseph Stringfellow Breakdown of academic impact, for papers by Stuart Kushner Breakdown of academic impact, for papers by P.V. Tran Breakdown of academic impact, for papers by Eva Kohegyi Breakdown of academic impact, for papers by A Breier Breakdown of academic impact, for papers by John Cookson Breakdown of academic impact, for papers by Margaretta Nyilas Breakdown of academic impact, for papers by David McDonnell
Rankless by CCL
2026